Cash flow HCA Healthcare, Inc.

Equities

HCA

US40412C1018

Healthcare Facilities & Services

Market Closed - Nyse Other stock markets 01:30:02 14/09/2024 am IST			5-day change	1st Jan Change
394.68 ^USD	+0.77%		+1.73%	+45.81%

12/09	Hca Healthcare Insider Sold Shares Worth $3,221,340, According to a Recent SEC Filing	MT
05/09	Transcript : HCA Healthcare, Inc. Presents at Morgan Stanley 22nd Annual Global Healthcare Conference, Sep-05-2024 03:20 PM

18334294a421aaf00c.8dmryqaNIDj3R1I8JQFX61ffFZTrXR9YY-irfa-3Xjo.nqvE_f7AT1GvN2B5d04inQW2WsaMLEkKM5zxKJnBDQiEvtKC3_lCdbZqFw

Published financial data: HCA HEALTHCARE, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2019	2020	2021	2022	2023
Revenues	5.13TCr	5.15TCr	5.88TCr	6.02TCr	6.5TCr
Total Revenues	5.13TCr	5.15TCr	5.88TCr	6.02TCr	6.5TCr
Cost of Goods Sold, Total	3.2TCr	3.23TCr	3.63TCr	3.71TCr	3.94TCr
Gross Profit	1.93TCr	1.92TCr	2.25TCr	2.32TCr	2.56TCr
Selling General & Admin Expenses, Total	86Cr	92Cr	99Cr	98Cr	99Cr
Depreciation & Amortization - (IS)	259.6Cr	272.1Cr	285.3Cr	296.9Cr	307.7Cr
Other Operating Expenses	862.6Cr	838.4Cr	897.2Cr	1.02TCr	1.19TCr
Other Operating Expenses, Total	1.21TCr	1.2TCr	1.28TCr	1.41TCr	1.6TCr
Operating Income	721.8Cr	720.2Cr	967.8Cr	905.3Cr	962.7Cr
Interest Expense, Total	-182.4Cr	-158.4Cr	-156.6Cr	-174.1Cr	-193.8Cr
Net Interest Expenses	-182.4Cr	-158.4Cr	-156.6Cr	-174.1Cr	-193.8Cr
Income (Loss) On Equity Invest.	4.3Cr	5.4Cr	11Cr	4.5Cr	2.2Cr
EBT, Excl. Unusual Items	543.7Cr	567.2Cr	822.5Cr	735.7Cr	771.1Cr
Gain (Loss) On Sale Of Investments	-	-	-	-	-
Gain (Loss) On Sale Of Assets	1.8Cr	-70L	162Cr	130.1Cr	-50L
Legal Settlements	-	-	-	-	-
Other Unusual Items	-21Cr	-24Cr	-1.2Cr	-7.8Cr	-
EBT, Incl. Unusual Items	524.4Cr	543Cr	983.3Cr	858Cr	770.6Cr
Income Tax Expense	109.9Cr	104.3Cr	211.2Cr	174.6Cr	161.5Cr
Earnings From Continuing Operations	414.5Cr	438.7Cr	772.1Cr	683.4Cr	609.1Cr
Net Income to Company	414.5Cr	438.7Cr	772.1Cr	683.4Cr	609.1Cr
Minority Interest	-64Cr	-63Cr	-76Cr	-119.1Cr	-85Cr
Net Income - (IS)	350.5Cr	375.4Cr	695.6Cr	564.3Cr	524.2Cr
Net Income to Common Incl Extra Items	350.5Cr	375.4Cr	695.6Cr	564.3Cr	524.2Cr
Net Income to Common Excl. Extra Items	350.5Cr	375.4Cr	695.6Cr	564.3Cr	524.2Cr
Per Share Items
Net EPS - Basic	10.27	11.1	21.51	19.44	19.24
Basic EPS - Continuing Operations	10.27	11.1	21.51	19.44	19.24
Basic Weighted Average Shares Outstanding	34Cr	34Cr	32Cr	29Cr	27Cr
Net EPS - Diluted	10.07	10.93	21.16	19.15	18.97
Diluted EPS - Continuing Operations	10.07	10.93	21.16	19.15	18.97
Diluted Weighted Average Shares Outstanding	35Cr	34Cr	33Cr	29Cr	28Cr
Normalized Basic EPS	8.08	8.61	13.53	11.73	14.58
Normalized Diluted EPS	7.92	8.47	13.31	11.56	14.36
Dividend Per Share	1.6	0.43	1.92	2.24	2.4
Payout Ratio	15.69	4.08	8.97	11.57	12.61
American Depositary Receipts Ratio (ADR)	0.05	0.05	0.05	0.05	0.05
Supplemental Items
EBITDA	981.4Cr	992.3Cr	1.25TCr	1.2TCr	1.27TCr
EBITA	723Cr	722.8Cr	970.3Cr	909.7Cr	964.7Cr
EBIT	721.8Cr	720.2Cr	967.8Cr	905.3Cr	962.7Cr
EBITDAR	1.07TCr	1.08TCr	1.35TCr	1.3TCr	1.37TCr
Total Revenues (As Reported)	-	-	-	-	-
Effective Tax Rate - (Ratio)	20.96	19.21	21.48	20.35	20.96
Current Domestic Taxes	80Cr	114.7Cr	208Cr	142.8Cr	133.1Cr
Current Foreign Taxes	1.7Cr	50L	1.5Cr	1.8Cr	30L
Total Current Taxes	82Cr	115.2Cr	209.5Cr	144.6Cr	133.4Cr
Deferred Domestic Taxes	28Cr	-11Cr	60L	29Cr	26Cr
Deferred Foreign Taxes	-50L	30L	1.1Cr	1.2Cr	1.9Cr
Total Deferred Taxes	28Cr	-11Cr	1.7Cr	30Cr	28Cr
Normalized Net Income	275.81Cr	291.2Cr	437.56Cr	340.71Cr	397.04Cr
Interest on Long-Term Debt	182.4Cr	158.4Cr	156.6Cr	174.1Cr	193.8Cr
Non-Cash Pension Expense	7.4Cr	6.7Cr	6.4Cr	-1.6Cr	5.2Cr
Supplemental Operating Expense Items
Net Rental Expense, Total	86Cr	92Cr	99Cr	98Cr	99Cr
Imputed Operating Lease Interest Expense	36Cr	34Cr	35Cr	35Cr	38Cr
Imputed Operating Lease Depreciation	49Cr	58Cr	63Cr	62Cr	62Cr
Stock-Based Comp., COGS (Total)	35Cr	36Cr	44Cr	34Cr	26Cr
Total Stock-Based Compensation	35Cr	36Cr	44Cr	34Cr	26Cr

Fiscal Period: December	2019	2020	2021	2022	2023
Assets
Cash And Equivalents	62Cr	179.3Cr	145.1Cr	91Cr	94Cr
Short Term Investments	15Cr	12Cr	10Cr	9.2Cr	8.7Cr
Total Cash And Short Term Investments	77Cr	190.9Cr	155.4Cr	100Cr	102.2Cr
Accounts Receivable, Total	738.9Cr	705.9Cr	810.6Cr	890.3Cr	996.6Cr
Total Receivables	738.9Cr	705.9Cr	810.6Cr	890.3Cr	996.6Cr
Inventory	184.9Cr	202.5Cr	198.6Cr	206.8Cr	202.1Cr
Deferred Tax Assets Current	-	-	-	-	-
Other Current Assets, Total	119Cr	134Cr	189.6Cr	167.2Cr	191.8Cr
Total Current Assets	1.12TCr	1.23TCr	1.35TCr	1.36TCr	1.49TCr
Gross Property Plant And Equipment	4.91TCr	5.13TCr	5.35TCr	5.68TCr	6.08TCr
Accumulated Depreciation	-2.45TCr	-2.61TCr	-2.73TCr	-2.92TCr	-3.08TCr
Net Property Plant And Equipment	2.45TCr	2.52TCr	2.62TCr	2.76TCr	2.99TCr
Long-term Investments	56Cr	81Cr	89Cr	120.4Cr	123.3Cr
Goodwill	793.9Cr	820.9Cr	913.7Cr	929.4Cr	960.6Cr
Other Intangibles, Total	33Cr	37Cr	40Cr	36Cr	34Cr
Accounts Receivable Long-Term	3.7Cr	3.1Cr	4.4Cr	4.8Cr	3.4Cr
Deferred Charges Long-Term	-	-	-	-	-
Other Long-Term Assets, Total	44Cr	52Cr	55Cr	25Cr	15Cr
Total Assets	4.51TCr	4.75TCr	5.07TCr	5.24TCr	5.62TCr
Liabilities
Accounts Payable, Total	290.5Cr	353.5Cr	411.1Cr	423.9Cr	423.3Cr
Accrued Expenses, Total	390Cr	402.1Cr	424.7Cr	433.3Cr	510.3Cr
Current Portion of Long-Term Debt	5.8Cr	8.1Cr	10Cr	24Cr	225.8Cr
Current Portion of Leases	44Cr	51Cr	54Cr	50Cr	53Cr
Other Current Liabilities	46Cr	56Cr	59Cr	60Cr	53Cr
Total Current Liabilities	775.7Cr	870.4Cr	958.2Cr	990.2Cr	1.27TCr
Long-Term Debt	3.31TCr	3.03TCr	3.38TCr	3.71TCr	3.66TCr
Long-Term Leases	196.9Cr	216.7Cr	233.2Cr	233.1Cr	244.4Cr
Other Non Current Liabilities	278.3Cr	338Cr	357.4Cr	314.3Cr	342.4Cr
Total Liabilities	4.56TCr	4.46TCr	4.93TCr	5.25TCr	5.52TCr
Common Stock, Total	30L	30L	30L	30L	30L
Additional Paid In Capital	-	29Cr	-	-	-
Retained Earnings	-235.1Cr	78Cr	-53Cr	-228Cr	-135.2Cr
Comprehensive Income and Other	-46Cr	-50Cr	-40Cr	-49Cr	-42Cr
Total Common Equity	-280.8Cr	57Cr	-93Cr	-276.7Cr	-177.4Cr
Minority Interest	224.3Cr	232Cr	242.2Cr	269.4Cr	283.4Cr
Total Equity	-56Cr	289.2Cr	148.9Cr	-7.3Cr	106Cr
Total Liabilities And Equity	4.51TCr	4.75TCr	5.07TCr	5.24TCr	5.62TCr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	34Cr	34Cr	30Cr	28Cr	26Cr
ECS Total Common Shares Outstanding	34Cr	34Cr	31Cr	28Cr	27Cr
Book Value / Share	-8.3	1.69	-3.05	-9.98	-6.68
Tangible Book Value	-1.11TCr	-800.6Cr	-1.05TCr	-1.24TCr	-1.17TCr
Tangible Book Value Per Share	-32.73	-23.59	-34.28	-44.78	-44.13
Total Debt	3.56TCr	3.31TCr	3.67TCr	4.02TCr	4.19TCr
Net Debt	3.48TCr	3.12TCr	3.52TCr	3.92TCr	4.08TCr
Debt Equivalent of Unfunded Proj. Benefit Obligation	42Cr	45Cr	46Cr	35Cr	33Cr
Debt Equivalent Oper. Leases	684Cr	738.4Cr	791.2Cr	780.8Cr	795.2Cr
Minority Interest, Total (Incl. Fin. Div)	224.3Cr	232Cr	242.2Cr	269.4Cr	283.4Cr
Equity Method Investments, Total	25Cr	42Cr	45Cr	82Cr	76Cr
Account Code - Inventory Valuation	5	5	5	5	5
Land - (BS)	217.8Cr	226.9Cr	249.6Cr	279.9Cr	312Cr
Buildings, Total	1.77TCr	1.85TCr	1.92TCr	2.02TCr	2.16TCr
Machinery, Total	2.58TCr	2.71TCr	2.83TCr	3TCr	3.2TCr
Full Time Employees	2L	2L	2L	2L	2L
Part Time Employees	70T	80T	80T	87T	90T
Accumulated Allowance for Doubtful Accounts (Supple)	695.3Cr	610.8Cr	678.4Cr	678Cr	728.3Cr

Fiscal Period: December	2019	2020	2021	2022	2023
Net Income	350.5Cr	375.4Cr	695.6Cr	564.3Cr	524.2Cr
Depreciation & Amortization - CF	258.4Cr	269.5Cr	282.8Cr	292.5Cr	305.7Cr
Amortization of Goodwill and Intangible Assets - (CF)	1.2Cr	2.6Cr	2.5Cr	4.4Cr	2Cr
Depreciation & Amortization, Total	259.6Cr	272.1Cr	285.3Cr	296.9Cr	307.7Cr
Amortization of Deferred Charges, Total - (CF)	3Cr	3Cr	2.7Cr	2.9Cr	3.5Cr
(Gain) Loss From Sale Of Asset	-1.8Cr	70L	-162Cr	-130.1Cr	50L
Stock-Based Compensation (CF)	35Cr	36Cr	44Cr	34Cr	26Cr
Other Operating Activities, Total	123Cr	108Cr	81Cr	199.3Cr	126.7Cr
Change In Accounts Receivable	-33Cr	33Cr	-96Cr	-80Cr	-94Cr
Change In Inventories	-16Cr	-30Cr	-54Cr	-5.9Cr	-13Cr
Change In Accounts Payable	40Cr	125.5Cr	100Cr	-30Cr	60Cr
Change in Other Net Operating Assets	-	-	-	-	-
Cash from Operations	760.2Cr	923.2Cr	895.9Cr	852.2Cr	943.1Cr
Capital Expenditure	-415.8Cr	-283.5Cr	-357.7Cr	-439.5Cr	-474.4Cr
Cash Acquisitions	-168.2Cr	-57Cr	-110.5Cr	-22Cr	-64Cr
Divestitures	6.1Cr	6.8Cr	216Cr	123.7Cr	19Cr
Investment in Marketable and Equity Securities, Total	2.5Cr	-2Cr	-12Cr	1.4Cr	-11Cr
Other Investing Activities, Total	3.4Cr	-3.8Cr	-40L	-2.1Cr	-1.9Cr
Cash from Investing	-572Cr	-339.3Cr	-264.3Cr	-338.9Cr	-531.7Cr
Long-Term Debt Issued, Total	645.1Cr	270Cr	712.4Cr	611.7Cr	322.4Cr
Total Debt Issued	645.1Cr	270Cr	712.4Cr	611.7Cr	322.4Cr
Long-Term Debt Repaid, Total	-588.4Cr	-591.7Cr	-386.9Cr	-283Cr	-192.9Cr
Total Debt Repaid	-588.4Cr	-591.7Cr	-386.9Cr	-283Cr	-192.9Cr
Repurchase of Common Stock	-103.1Cr	-44Cr	-821.5Cr	-700Cr	-381.1Cr
Common Dividends Paid	-55Cr	-15Cr	-62Cr	-65Cr	-66Cr
Common & Preferred Stock Dividends Paid	-55Cr	-15Cr	-62Cr	-65Cr	-66Cr
Other Financing Activities, Total	-76Cr	-87Cr	-107.1Cr	-129Cr	-92Cr
Cash from Financing	-177.1Cr	-467.7Cr	-665.5Cr	-565.6Cr	-409.4Cr
Foreign Exchange Rate Adjustments	80L	1Cr	-30L	-2Cr	70L
Net Change in Cash	12Cr	117.2Cr	-34Cr	-54Cr	2.7Cr
Supplemental Items
Cash Interest Paid	191.4Cr	160.7Cr	150.2Cr	166.2Cr	189.2Cr
Cash Income Tax Paid (Refund)	85Cr	100.2Cr	218.2Cr	117.5Cr	138.6Cr
Levered Free Cash Flow	190.32Cr	464.72Cr	407.8Cr	308.2Cr	287.36Cr
Unlevered Free Cash Flow	301.32Cr	560.72Cr	502.98Cr	414.11Cr	404.99Cr
Change In Net Working Capital	28Cr	-86Cr	74Cr	43Cr	56Cr
Net Debt Issued / Repaid	57Cr	-321.7Cr	325.5Cr	328.7Cr	129.5Cr

Fiscal Period: December	2019	2020	2021	2022	2023
Profitability
Return on Assets	10.71	9.73	12.32	10.97	11.08
Return on Total Capital	13.89	12.68	16.3	14.44	14.49
Return On Equity %	-238.01	377.05	352.48	965.25	1.23T
Return on Common Equity	-90.36	-335.78	-3.85T	-305.03	-230.87
Margin Analysis
Gross Profit Margin %	37.59	37.32	38.28	38.48	39.37
SG&A Margin	1.67	1.79	1.68	1.62	1.53
EBITDA Margin %	19.12	19.26	21.33	19.96	19.55
EBITA Margin %	14.08	14.03	16.52	15.1	14.85
EBIT Margin %	14.06	13.98	16.47	15.03	14.82
Income From Continuing Operations Margin %	8.07	8.51	13.14	11.35	9.38
Net Income Margin %	6.83	7.28	11.84	9.37	8.07
Net Avail. For Common Margin %	6.83	7.28	11.84	9.37	8.07
Normalized Net Income Margin	5.37	5.65	7.45	5.66	6.11
Levered Free Cash Flow Margin	3.71	9.02	6.94	5.12	4.42
Unlevered Free Cash Flow Margin	5.87	10.88	8.56	6.88	6.23
Asset Turnover
Asset Turnover	1.22	1.11	1.2	1.17	1.2
Fixed Assets Turnover	2.32	2.07	2.29	2.24	2.26
Receivables Turnover (Average Receivables)	7.24	7.13	7.75	7.08	6.89
Inventory Turnover (Average Inventory)	17.9	16.68	18.08	18.28	19.27
Short Term Liquidity
Current Ratio	1.44	1.42	1.41	1.38	1.18
Quick Ratio	1.05	1.03	1.01	1	0.87
Operating Cash Flow to Current Liabilities	0.98	1.06	0.93	0.86	0.75
Days Sales Outstanding (Average Receivables)	50.44	51.31	47.11	51.54	53
Days Outstanding Inventory (Average Inventory)	20.4	21.95	20.19	19.97	18.95
Average Days Payable Outstanding	31.11	36.29	38.52	41.03	39.3
Cash Conversion Cycle (Average Days)	39.72	36.97	28.77	30.47	32.65
Long Term Solvency
Total Debt/Equity	-6.3T	1.14T	2.47T	-55.07T	3.95T
Total Debt / Total Capital	101.61	91.97	96.1	100.18	97.53
LT Debt/Equity	-6.21T	1.12T	2.42T	-54.06T	3.69T
Long-Term Debt / Total Capital	100.2	90.33	94.44	98.35	91.04
Total Liabilities / Total Assets	101.25	93.91	97.07	100.14	98.11
EBIT / Interest Expense